Utility of immunophenotyping of plasma cells in multiple myeloma

被引：1

作者：

Gertz, Morie A. ^{[1
]}

Buadi, Francis K. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

LEUKEMIA & LYMPHOMA | 2016年 / 57卷 / 02期

关键词：

FLOW-CYTOMETRY; DETAILED CHARACTERIZATION; MONOCLONAL GAMMOPATHY;

D O I：

10.3109/10428194.2015.1068310

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：252 / 253

页数：2

共 21 条

[1]

Almeida J, 1999, PATHOL BIOL, V47, P119

[2]

Bataille R, 2006, HAEMATOLOGICA, V91, P1234

[3] Utility of Nine-Color, 11-Parameter Flow Cytometry for Detection of Plasma Cell Neoplasms A Comparison With Bone Marrow Morphologic Findings and Concurrent M-Protein Studies in Serum and Urine [J].

Behdad, Amir ;

Ross, Charles W. ;

Jacques, Joshua ;

Kota, Usha ;

Keren, David ;

Stoolman, Lloyd .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (03) :398-410

[4] High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma [J].

Bianchi, G. ;

Kyle, R. A. ;

Larson, D. R. ;

Witzig, T. E. ;

Kumar, S. ;

Dispenzieri, A. ;

Morice, W. G. ;

Rajkumar, S. V. .

LEUKEMIA, 2013, 27 (03) :680-685

[5] Multiparameter Immunophenotyping by Flow Cytometry in Multiple Myeloma: The Diagnostic Utility of Defining Ranges of Normal Antigenic Expression in Comparison to Histology [J].

Cannizzo, Elisa ;

Bellio, Emanuele ;

Sohani, Aliyah R. ;

Hasserjian, Robert P. ;

Ferry, Judith A. ;

Dorn, Michelle E. ;

Sadowski, Craig ;

Bucci, Janessa J. ;

Carulli, Giovanni ;

Preffer, Frederic .

CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (04) :231-238

[6] Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells [J].

Caraux, Anouk ;

Klein, Bernard ;

Paiva, Bruno ;

Bret, Caroline ;

Schmitz, Alexander ;

Fuhler, Gwenny M. ;

Bos, Nico A. ;

Johnsen, Hans E. ;

Orfao, Alberto ;

Perez-Andres, Martin .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06) :1016-1020

[7] Is CD20 positive plasma cell myeloma a unique clinicopathological entity? A study of 40 cases and review of the literature [J].

Grigoriadis, George ;

Gilbertson, Michael ;

Came, Neil ;

Westerman, David ;

Fellepa, Frank ;

Jene, Nick ;

Chapple, Peter ;

Juneja, Surender .

PATHOLOGY, 2012, 44 (06) :552-556

[8] CD20-positive multiple myeloma: can conventional chemotherapy still be used to achieve ideal outcome for these patients? [J].

Huang, Beihui ;

Li, Juan ;

Liu, Junru ;

Gu, Jingli .

LEUKEMIA & LYMPHOMA, 2016, 57 (02) :335-340

[9] Anti-CD20 monoclonal antibody therapy in multiple myeloma [J].

Kapoor, Prashant ;

Greipp, Patricia T. ;

Morice, William G. ;

Rajkumar, S. Vincent ;

Witzig, Thomas E. ;

Greipp, Philip R. .

BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) :135-148

[10] Molecular pathogenesis of multiple myeloma and its premalignant precursor [J].

Kuehl, W. Michael ;

Bergsagel, P. Leif .

JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10) :3456-3463

← 1 2 3 →